|
⚲
|
| Keyboard |
| Gunderson Robert V JR
✚
|
|
|---|---|
| CIK # | 0001302450 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001302450] | |
| 4 | [0001302450] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Andersen Group Inc | |
| Gunderson Robert V JR | |
| Theravance Biopharma Inc | |
| Vitae Pharmaceuticals Inc | |
| Theravance Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Andersen Group Inc ANDG
Class A Common Stock
|
2025-12-18 | Buy | 12,633 | $16.00 | 202,128 |
|
Theravance Biopharma Inc TBPH
Share Option (Right to Buy) · derivative
|
2021-04-27 | Grant | 6,000 | $0.00 | |
|
Theravance Biopharma Inc TBPH
Ordinary Shares
|
2021-04-27 | Grant | 9,828 | $0.00 | |
|
Theravance Biopharma Inc TBPH
Ordinary Shares
|
2020-04-28 | Grant | 6,635 | $0.00 | |
|
Theravance Biopharma Inc TBPH
Share Option (Right to Buy) · derivative
|
2020-04-28 | Grant | 6,000 | $0.00 | |
|
Theravance Biopharma Inc TBPH
Ordinary Shares
|
2019-04-30 | Grant | 8,385 | $0.00 | |
|
Theravance Biopharma Inc TBPH
Share Option (Right to Buy) · derivative
|
2019-04-30 | Grant | 6,000 | $0.00 | |
|
Theravance Biopharma Inc TBPH
Ordinary Shares
|
2018-05-01 | Grant | 8,186 | $0.00 | |
|
Theravance Biopharma Inc TBPH
Share Option (Right to Buy) · derivative
|
2018-05-01 | Grant | 6,000 | $0.00 | |
|
Theravance Biopharma Inc TBPH
Ordinary Shares
|
2017-05-17 | Grant | 6,000 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Stock Option (Right to Buy) · derivative
|
2016-10-25 | Disposed to issuer | 17,000 | $13.00 | 221,000 |
|
Vitae Pharmaceuticals Inc VTAE
Stock Option (Right to Buy) · derivative
|
2016-10-25 | Disposed to issuer | 10,000 | $11.38 | 113,800 |
|
Vitae Pharmaceuticals Inc VTAE
Stock Option (Right to Buy) · derivative
|
2016-10-25 | Disposed to issuer | 10,000 | $8.57 | 85,700 |
|
Vitae Pharmaceuticals Inc VTAE
Stock Option (Right to Buy) · derivative
|
2016-10-25 | Disposed to issuer | 5,434 | $17.09 | 92,867 |
|
Vitae Pharmaceuticals Inc VTAE
Stock Option (Right to Buy) · derivative
|
2016-10-25 | Disposed to issuer | 9,091 | $15.71 | 142,820 |
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2016-10-24 | Tender | 11,002 | $21.00 | 231,042 |
|
Vitae Pharmaceuticals Inc VTAE
Common Stock
|
2016-10-24 | Tender | 15,830 | $21.00 | 332,430 |
|
Vitae Pharmaceuticals Inc VTAE
Stock Option (Right to Buy) · derivative
|
2016-05-26 | Grant | 10,000 | $0.00 | |
|
Theravance Biopharma Inc TBPH
Ordinary Shares
|
2016-05-03 | Grant | 6,000 | $0.00 | |
|
Vitae Pharmaceuticals Inc VTAE
Stock Option (Right to Buy) · derivative
|
2015-05-28 | Grant | 10,000 | $0.00 | |
| showing 20 of 36 most recent transactions | |||||